XBiotech Inc. (XBIT) › Operating IncomeXBiotech Inc. (XBIT) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2013: -$9.93M2014: -$21.78M2015: -$37.51M2016: -$52.76M2017: -$34.06M2018: -$20.99M2019: -$31.23M2020: -$18.28M2021: -$25.08M2022: -$34.49M2023: -$37.51M2024: -$42.47M2025: -$55.69M-$55.69M2013Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$55.69M-31.1%2024-$42.47M-13.2%2023-$37.51M-8.8%2022-$34.49M-37.5%2021-$25.08M-37.2%2020-$18.28M+41.5%2019-$31.23M-48.8%2018-$20.99M+38.4%2017-$34.06M+35.4%2016-$52.76M-40.7%2015-$37.51M-72.2%2014-$21.78M-119.4%2013-$9.93M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share